Skip to content
The San Francisco

FDA approves Moderna's mRNA seasonal flu vaccine

FDA approves Moderna's mRNA seasonal flu vaccine
Photo: ABC7 News (KGO-TV, ABC) · view original

The vaccine, mFLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.

Sources and story details